AF-106

N/A

Report date: 2025/03/26 11:40:41
NME

Base Information

Drug NameAF-106
Drug Alias NameAF-106
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRare hematological diseaseInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfimmune Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAfimmune Ltd
Inactive CompaniesN/A
Active IndicationsRare hematological disease
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A